UK-US agree zero tariff deal on pharmaceuticals
The UK and US have struck a deal to maintain 0% tariffs on medicines for three years, alongside NHS commitments to increase spending on new drugs. Discover the implications for patients and industry.
Category : Search result: pharmaceutical independence
ADHD medication recalled over effectiveness issues
A popular generic ADHD medication is being recalled nationwide after tests showed it may not dissolve properly, failing to deliver the full dose. Patients urged to check their prescriptions.
Civil servants forced into independence paper meetings
Scottish Government officials have been compelled to attend multiple meetings to accelerate work on a new independence prospectus, sparking concerns about civil service neutrality and taxpayer resources being used for constitutional campaigning.
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
UK probes Pfizer and Novo Nordisk investments
The UK government launches a national security probe into major pharmaceutical investments by US-based Pfizer and Denmark's Novo Nordisk, raising concerns about foreign influence in Britain's vital healthcare sector.
FDA Recalls Blood Pressure Drug Over Cancer Risk
Patients across the UK prescribed Prazosin for blood pressure or prostate issues face urgent medication recall after FDA discovers dangerous carcinogens in tablets. Multiple manufacturers affected.
Trump pressured FDA over autism drug approval
Exclusive investigation reveals Donald Trump's relentless pressure on FDA officials to fast-track leucovorin for autism treatment despite limited scientific evidence and expert warnings.
Blood Pressure Drug Recalled Over Contamination Fears
A critical safety alert has been issued for specific batches of Prazosin Hydrochloride tablets after potential contamination was discovered. Patients advised to check their medication immediately.
Alan Kilburn: Pharmacy Visionary Who Revolutionised Medicine
Celebrating the extraordinary life of pharmacist Alan Kilburn, whose pioneering work revolutionised medicine dispensing and championed patient care across the UK.
Novo Nordisk bids for obesity biotech Metsera, challenging Pfizer
Danish pharmaceutical giant Novo Nordisk enters bidding war with Pfizer for obesity biotech firm Metsera, signalling major shift in weight-loss treatment market competition.
Ireland faces €13.4bn corporate tax shortfall
Ireland's Department of Finance confronts a staggering €13.4bn corporate tax shortfall as tech and pharmaceutical giants see profits decline, threatening the nation's economic stability.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
Pharmacy Visionary Robert Wilkinson Dies at 86
Tributes pour in for pioneering pharmacist Robert Wilkinson, whose groundbreaking work revolutionised NHS patient care and established new standards for community pharmacy across Britain.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
GSK shares tumble nearly 10% on HIV drug trial results
Pharmaceutical giant GSK faces significant market pressure as its experimental HIV prevention drug shows mixed results in clinical trials, sending shares tumbling nearly 10%.
UK productivity downgrade sparks tax rise fears
Britain faces a stark economic reckoning as official forecasts slash productivity growth, triggering speculation about imminent tax rises while major corporations voice concerns over investment climate.
Major Statin Recall: 140,000 Bottles Withdrawn
Urgent medication safety warning as cholesterol drug Atorvastatin faces massive recall over contamination fears. FDA investigation reveals critical manufacturing issues.
New Alzheimer's Drug Slows Brain Decline in Trial
A pioneering new treatment has demonstrated remarkable success in slowing memory loss and cognitive decline in Alzheimer's patients, offering fresh hope for millions affected by the devastating condition.
NHS patients denied vital medications in supply crisis
Exclusive investigation reveals how NHS patients across Britain are being denied essential medicines due to catastrophic supply chain failures, with government accused of prioritising pharmaceutical profits over public health.
Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Moderna's Oxfordshire vaccine centre gets green light
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
PM: Swinney 'insults Scots' over secret independence plan
Rishi Sunak launches blistering attack on Scotland's First Minister John Swinney over alleged covert independence plan, accusing him of treating Scottish voters 'with contempt' in explosive Westminster clash.
Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Trump's Ozempic Price Pledge Shakes Pharma Markets
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
California declares emergency over insulin prices
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Trump's FDA Win: IVF Drug Approved Despite Opposition
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
New weight loss jab shows unprecedented 24% reduction
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
J&J Pays $700M in Talc Cancer Scandal Settlement
Pharmaceutical giant Johnson & Johnson agrees to pay $700 million settlement amid allegations their talcum powder contained asbestos and caused ovarian cancer in thousands of women.
Johnson & Johnson Faces UK Lawsuit Over Talc Cancer Claims
Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.
Johnson & Johnson £50B talc cancer settlement
Pharmaceutical giant Johnson & Johnson agrees to pay £50 billion to settle claims its talcum powder caused cancer, while continuing to deny product safety concerns.
Page 1 of 4